SVRA Archived Articles
Savara Inc. (NASDAQ:SVRA): A Clinical-Stage Biotech Tackling Rare Respiratory Diseases
Published on March 17, 2025
Savara Inc. (NASDAQ:SVRA): A Promising Rare Respiratory Disease Specialist Poised for Growth
Published on September 24, 2024